L. Davidson, J. M. van den Reek, F. van Hunsel, E. M. de Jong, and B. J. Kullberg, “Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center”, Acta Derm Venereol, vol. 102, p. adv00648, Feb. 2022.